top of page
Search

Sensydia Completes Series A Financing

Sensydia Corporation has completed its first round of financing which will be used to develop its patent pending technology to detect critical heart function measures such as Ejection Fraction, Stroke Volume, Cardiac Output, and many heart disease conditions.



コメント


10880 Wilshire Blvd Suite 1101, Office 1148

Los Angeles, CA 90024

info@sensydia.com

 

 

 

 

 


 

© 2023 Sensydia

Senydia logo wide white
  • LinkedIn
  • Twitter
bottom of page